Needham analyst Mike Matson raised the price target on Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) to $9.00 (from $4.25) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE